Skip to content

A single-center study on intravenous thrombolysis for ischaemic stroke in Dalian, China

A single-center study on intravenous thrombolysis for ischaemic stroke in Dalian, China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089803
Enrollment
Unknown
Registered
2024-09-14
Start date
2024-10-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Venous thrombolysis group (Treatment was performed using standard doses of thrombolytic drugs based on clinical medication guidelines):

Sponsors

Affiliated Central Hospital of Dalian University of Technology(Dalian Central Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age 18 years; met the Chinese Guidelines for Diagnosis and Treatment of Acute Ichaemic Stroke; met the indications for thrombolysis and used thrombolytic drugs in the time window; agreed to participate in the study and gave informed consent for the collection and preservation of case data and follow-up process.

Exclusion criteria

Exclusion criteria: The patient is contraindication to thrombolysis; no informed consent; any other investigator deemed not fit to participate in the study.

Design outcomes

Primary

MeasureTime frame
Die;

Secondary

MeasureTime frame
Hemorrhage transformation;Neurological function recovery outcome;

Countries

Chnia

Contacts

Public ContactDong Chen

Affiliated Central Hospital of Dalian University of Technology(Dalian Central Hospital)

neuro-chen@dlut.edu.cn+86 84412001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026